Shinya Nakatani, Haruna Kawano, Mai Sato, Junichi Hoshino, Saori Nishio, Kenichiro Miura, Akinari Sekine, Tatsuya Suwabe, Sumi Hidaka, Hiroshi Kataoka, Eiji Ishikawa, Keiji Shimazu, Kiyotaka Uchiyama, Takuya Fujimaru, Tomofumi Moriyama, Mahiro Kurashige, Wataru Shimabukuro, Fumihiko Hattanda, Tomoki Kimura, Yusuke Ushio, Shun Manabe, Hirofumi Watanabe, Michihiro Mitobe, Koichi Seta, Yosuke Shimada, Hirayasu Kai, Kan Katayama, Daisuke Ichikawa, Hiroki Hayashi, Kazushige Hanaoka, Toshio Mochizuki, Koichi Nakanishi, Ken Tsuchiya, Shigeo Horie, Yoshitaka Isaka, Satoru Muto
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) are major genetic polycystic kidney diseases that can progress to end-stage kidney disease (ESKD). Longitudinal data on the clinical characteristics associated with clinical outcomes in polycystic kidney disease (PKD), including the development of ESKD and cardiovascular disease (CVD) are lacking in Japan. To address this unmet need the authors are establishing a novel, web-based, Nationwide Cohort Registry Study-the Japanese Registry of PKD (JRP)...
May 11, 2024: Clinical and Experimental Nephrology